Article

EEG spectral phenotypes: heritability and association with marijuana and alcohol dependence in an American Indian community study.

Department of Molecular and Integrative Neurosciences, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Drug and alcohol dependence (Impact Factor: 3.28). 09/2009; 106(2-3):101-10. DOI: 10.1016/j.drugalcdep.2009.07.024
Source: PubMed

ABSTRACT Native Americans have some of the highest rates of marijuana and alcohol use and abuse, yet neurobiological measures associated with dependence on these substances in this population remain unknown. The present investigation evaluated the heritability of spectral characteristics of the electroencephalogram (EEG) and their correlation with marijuana and alcohol dependence in an American Indian community. Participants (n=626) were evaluated for marijuana (MJ) and alcohol (ALC) dependence, as well as other psychiatric disorders. EEGs were collected from six cortical sites and spectral power determined in five frequency bands (delta 1.0-4.0 Hz, theta 4.0-7.5 Hz, alpha 7.5-12.0 Hz, low beta 12.0-20.0 Hz and high beta/gamma 20-50 Hz). The estimated heritability (h(2)) of the EEG phenotypes was calculated using SOLAR, and ranged from 0.16 to 0.67. Stepwise linear regression was used to detect correlations between MJ and ALC dependence and the spectral characteristics of the EEG using a model that took into account: age, gender, Native American Heritage (NAH) and a lifetime diagnosis of antisocial personality and/or conduct disorder (ASPD/CD). Increases in spectral power in the delta frequency range, were significantly correlated with gender (p<0.001) and marijuana dependence (p<0.003). Gender, age, NAH and ASPD/CD were all significantly (p<0.001) correlated with theta, alpha and beta band power, whereas alcohol dependence (p<0.01), gender (p<0.001), and ASPD/CD (p<0.001) were all correlated with high beta/gamma band power. These data suggest that the traits of EEG delta and high beta/gamma activity are correlated with MJ dependence and alcohol dependence, respectively, in this community sample of Native Americans.

1 Follower
 · 
114 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Several EEG parameters are potential endophenotypes for different psychiatric disorders. The present study consists of a comprehensive behavioral- and molecular-genetic analysis of such parameters in a large community sample (N = 4,026) of adolescent twins and their parents, genotyped for 527,829 single nucleotide polymorphisms (SNPs). Biometric heritability estimates ranged from .49 to .85, with a median of .78. The additive effect of all SNPs (SNP heritability) varied across electrodes. Although individual SNPs were not significantly associated with EEG parameters, several genes were associated with delta power. We also obtained an association between the GABRA2 gene and beta power (p < .014), consistent with findings reported by others, although this did not survive Bonferroni correction. If EEG parameters conform to a largely polygenic model of inheritance, larger sample sizes will be required to detect individual variants reliably.
    Psychophysiology 12/2014; 51(12):1225-45. DOI:10.1111/psyp.12344 · 3.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: This project showcases the prevalence of alcohol and other drug (AOD) use by American Indians in the northern plains region. American Indians/ Alaska Natives (AI/AN) have some of the highest rates of marijuana and alcohol use and abuse, yet neurobiological measures associated with dependence on these substances in this population remain unknown (Ehlers, Phillips, Gizer, Gilder, & Wilhelmsen, 2010). Gaining a better understanding of the behavioral health needs of particular racial/ethnic groups can help inform public health policy, build prevention and treatment programs that target the different needs of these populations, and expand access to services for individuals who need them (The NSDUH Report, 2010). The high prevalence rate of alcohol and other drugs (AOD) use by AI/ANs must be understood in light of their unique history. Moderating factors such as health status, education level, quality of life, socioeconomic status, cultural identification, and historical trauma may contribute to use of alcohol and other drug (Szlemko, Wood, & Thurman, 2006). These findings add to the sparse collection of available literature on AOD use among AI/AN populations Methods: Six hundred male and female adult, Northern Plains Indians were recruited from IHS and tribal behavioral health clinics on seven North and South Dakota Reservations to complete a series of mood disorder assessments. The participants were recruited from three groups: 1) diagnosed depressed (by clinician), 2) diagnosed anxious (by clinician), and 3) no mental health diagnosis (control). Assessments were completed by paper and pencil, placed in an envelope and returned to the site coordinator. Participants received $10 in gift/gas cards in compensation for their time and the tribes received $5/participant for compensation. Site coordinators added the clinical diagnoses to the envelopes and returned them in separate envelopes from the consent forms to the researchers. Data was then entered using SPSS for all returned measures. Assessments included depression, anxiety, hopelessness, rumination, culture, quality of life, substance abuse, substance use, demographics, and the clinician’s diagnosis code. Results: A total of 600 participants from eight approved sites completed assessments: 233 males and 360 females between the ages of 18 and 80 years with a mean age was 36.2 years with a standard deviation of 12.7 years. Seventy-nine percent of participants had at least a high school education and 54% had household incomes below $8,000/year, 55.6% were single, and 37.9% are currently unemployed. As expected alcohol (52%) and cigarette (65.3%) usages were the most common type of substances used by NPI and the general population (55.2%; 20.6%) and AIAN as a group (43.9; 23.2%). Participants with no mental health diagnosis used tobacco less in the past month than those who have mental health diagnosis (56.4% vs. 76%). More of those with a mental health diagnosis smoked frequently (62.1%) than those with no mental health diagnosis (38.9%). Similarly, those with mental health diagnoses used alcohol in the past month more than those with no mental health diagnosis (48 vs.38.5%). This was also true of binge alcohol drinking (45.5% vs. 30.8%) Participants with a mental health diagnosis were twice as likely to use marijuana in the past month compared to those having no diagnosis (16.2% vs. 8%). Age groupings were examined: 18-25 years old smoked marijuana (13.4%) more than any other age group, 31-35 years old had the highest cocaine usage (14.3%) 36-40 year olds had the highest methamphetamine usage (16.3%). All substance use decreases in participants over the age of 45. Further Findings: 1) Male>Female use in all AOD categories, except methamphetamine where both groups have similar use at about 21%. 2) Participants with a diagnosed mental health problem used more AOD (48%) than those with no mental health diagnosis (38.5%). 3) Younger adults use more AOD than older adults with dramatic decrease after 45 years of age. 4) Marijuana use peaks in the 18-25 age group, cocaine peaks in the 31-35 age group, and methamphetamine peaks in the 36-40 age group. 5) Illicit drug use among AI/AN nationally were higher than the general population (18.3% vs. 8.8%). 6) Current alcohol use among NPI is lower than general population (16.8 % vs. 56.7%). AI/AN nationally (37.1%), is higher than NPI, and lower than the general population. 7) Binge drinking of alcohol among NPI is than lower than general population (11.2% vs. 24.8%). Rates of AI/AN nationally (22.2%), is higher than NPI, and but lower than the general population. 8) Tobacco Use among NPI is than lower than general population (21.6 % vs. 29.6%). AI/AN nationally (41.8%), is higher than NPI and the general population. References: Ehlers, C., Phillips, E., Gizer, I., Gilder, D., & Wilhelmsen, K. (2010). EEG spectral phenotypes: Heritability and association with marijuana and alcohol dependence in an American Indian community study. Drug and Alcohol Dependence, 106(2-3), 101-110. doi:10.1016/j.drugalcdep.2009.07.024. Szlemko, W., Wood, J., & Thurman, P. (2006). Native Americans and Alcohol: Past, Present, and Future. Journal of General Psychology, 133(4), 435-451. doi:10.3200/GENP.133.4.435-451. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (June 24, 2010). The NSDUH Report: Substance Use among American Indian or Alaska Native Adults. Rockville, MD. Retrieved from http://www.oas.samhsa.gov/2k10/182/AmericanIndian.htm#backtofootnote1 This research supported by grant # U26IHS300127 from IHS and NIDA. The University
    American Psychological Association, Washington, DC; 08/2011
  • [Show abstract] [Hide abstract]
    ABSTRACT: We mapped ∼85,000 rare nonsynonymous exonic single nucleotide polymorphisms (SNPs) to 17 psychophysiological endophenotypes in 4,905 individuals, including antisaccade eye movements, resting EEG, P300 amplitude, electrodermal activity, affect-modulated startle eye blink. Nonsynonymous SNPs are predicted to directly change or disrupt proteins encoded by genes and are expected to have significant biological consequences. Most such variants are rare, and new technologies can efficiently assay them on a large scale. We assayed 247,870 mostly rare SNPs on an Illumina exome array. Approximately 85,000 of the SNPs were polymorphic, rare (MAF < .05), and nonsynonymous. Single variant association tests identified a SNP in the PARD3 gene associated with theta resting EEG power. The sequence kernel association test, a gene-based test, identified a gene PNPLA7 associated with pleasant difference startle, the difference in startle magnitude between pleasant and neutral images. No other single nonsynonymous variant, or gene-based group of variants, was strongly associated with any endophenotype.
    Psychophysiology 12/2014; 51(12):1300-1308. DOI:10.1111/psyp.12349 · 3.18 Impact Factor

Preview

Download
0 Downloads
Available from